Diabetes Type 2 (also called adult-onset diabetes), is the most common type
of diabetes, affecting 85% to 90% of all diabetics. It is more likely to affect
older, sedentary, and overweight individuals with a family history of diabetes.
In this case, the pancreas makes some insulin but interaction mechanism of
insulin with cells is violated (insulin resistibility). Then how to treat
Diabetes Type 2 effectively?
Conventionally, persons with this disease often control their blood glucose
concentrations through a combination of diet, exercise, and oral medication.
However, over time most patients will also progress to the stage when only
insulin therapy will control the glucose levels in the blood.
Traditional treatments can not guarantee a satisfactory effect. Actually, in
order to treat Diabetes Type 2 from the root, we need to eliminate the root
cause-abnormal β-cells of pancreas. Immunotherapy can help us realize this
goal.
Application of Immunotherapy in case of this disease is proved by great
number of clinical practices. In our hospital, mesenchymal Immunotherapy and
Immunotherapy blood Immunotherapy are mainly chosen to successfully treat
diabetes and various kidney diseases.
Immunotherapy are unspecialized cells capable of renewing themselves through
cells division and differentiating into specific cells with special functions.
With appropriate culture, they can regenerate desired cells.
During the process of Type 2 Diabetes treatment, we can infuse proper amount
of Immunotherapy into patient's body through veins. They will differentiate into
healthy β-cells of pancreas so as to enhance the production of endogenous
insulin. Moreover, the C Peptide levels get increased and elevated blood sugar
levels are regulated. So the disease can be treated effectively with
Immunotherapy.